A total of 1799 differentially methylated cytosines in enhancers were observed, which were predicted to target 2885 genes, including various PD risk genes (such as DJ-1 and PRKN) as well as TET2 (which plays a key role in DNA hydroxymethylation—see next section). This evidence concerns the gene PARK7 and Parkinson disease.